 | Up a level |
Behringer, K., Thielen, I., Mueller, H., Goergen, H., Eibl, A. D., Rosenbrock, J., Halbsguth, T., Eichenauer, D. A., Fuchs, M., Reiners, K. S., Renno, J. H., van der Ven, K., Kuehr, M., von Wolff, M., Diehl, V., Engert, A. and Borchmann, P. (2020). Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial (vol 23, pg 1818, 2012). Ann. Oncol., 31 (8). S. 1093 - 1094. AMSTERDAM: ELSEVIER. ISSN 1569-8041
Boell, B., Pluetschow, A., Eichenauer, D. A., Thielen, I, von Tresckow, B., Atta, J., Pfreundschuh, M., Feuring-Buske, M., Vogelhuber, M., Soekler, M., Fuchs, M., Engert, A. and Borchmann, P. (2014). German Hodgkin Study Group Phase I trial of Doxorubicin, Vinblastine, Dacarbazine, and Lenalidomide (AVD-Rev) for elderly Hodgkin Lymphoma patients. Oncol. Res. Treat., 37. S. 12 - 13. BASEL: KARGER. ISSN 2296-5262
Eichenauer, D. A., Aleman, B. M. P., Andre, M., Federico, M., Hutchings, M., Illidge, T., Engert, A. and Ladetto, M. (2018). Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol., 29. S. 19 - 30. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041
Eichenauer, D. A., Engert, A., Andre, M., Federico, M., Illidge, T., Hutchings, M. and Ladetto, M. (2014). Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol., 25. S. 70 - 76. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041
Eichenauer, D. A., Engert, A. and Dreyling, M. (2011). Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol., 22. S. vi55 - 4. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041
Eichenauer, D. A., Goergen, H., Pluetschow, A., Wongso, D., Behringer, K., Kreissl, S., Thielen, I., Halbsguth, T., Broeckelmann, P. J., Fuchs, M., Boell, B., von Tresckow, B., Borchmann, P. and Engert, A. (2016). Ofatumumab in relapsed nodular lymphocyte-predominant Hodgkin lymphoma: results of a phase II study from the German Hodgkin study group. Leukemia, 30 (6). S. 1425 - 1429. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551
Eichenauer, D. A., Kreissl, S., Buehnen, I., Baues, C., Kobe, C., van Heek, L., Goergen, H., Fuchs, M., Hartmann, S., von Tresckow, B., Engert, A. and Borchmann, P. (2021). PET-2-guided escalated BEACOPP for advanced nodular lymphocyte-predominant Hodgkin lymphoma: a subgroup analysis of the randomized German Hodgkin Study Group HD18 study. Ann. Oncol., 32 (6). S. 807 - 811. AMSTERDAM: ELSEVIER. ISSN 1569-8041
Eichenauer, D. A., Kreissl, S., Buehnen, I., Goergen, H., Hartmann, S., Fuchs, M., von Tresckow, B., Engert, A. and Borchmann, P. (2020). PET-2-guided escalated BEACOPP for patients with advanced nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group. Oncol. Res. Treat., 43 (SUPPL 4). S. 87 - 89. BASEL: KARGER. ISSN 2296-5262
Eichenauer, D. A., Lachmann, G. and La Rosee, P. (2021). Hemophagocytic lymphohistiocytosis in critically ill patients. Med. Klin.-Intensivmed Notfallmed., 116 (2). S. 129 - 135. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 2193-6226
Eichenauer, D. A., Pluetschow, A., Fuchs, M., von Tresckow, B., Borchmann, P. and Engert, A. (2017). Long-term outcome of patients with early-stage nodular lymphocyte-predominant hodgkin lymphoma (NLPHL) treated within the randomized HD7, HD10 and HD13 trials: An analysis from the German Hodgkin Study Group (GHSG). Oncol. Res. Treat., 40. S. 142 - 143. BASEL: KARGER. ISSN 2296-5262
Eichenauer, D. A., Pluetschow, A., Fuchs, M., von Tresckow, B., Diehl, V., Borchmann, P. and Engert, A. (2017). LONG-TERM OUTCOME OF PATIENTS WITH NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN LYMPHOMA TREATED WITHIN THE RANDOMIZED HD7-HD15 TRIALS: AN ANALYSIS FROM THE GERMAN HODGKIN STUDY GROUP. Haematologica, 102. S. 82 - 83. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078
Ferdinandus, J., Oertel, M., Eichenauer, D. A., Meissner, J., Engert, A. and Borchmann, P. (2022). Advanced-stage Hodgkin lymphoma. Onkologie, 28 (10). S. 889 - 901. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 2731-7234
Kochanek, M., Shimabukuro-Vornhagen, A., Eichenauer, D. A. and Boell, B. (2020). Cardiovascular therapy for sepsis: when, how and how much? Internist, 61 (10). S. 997 - 1002. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Kreissl, S., Eichenauer, D. A., Meissner, J., Topp, M. S., Engert, A. and Borchmann, P. (2018). New developments in the treatment of advanced classical Hodgkin's lymphoma. Onkologe, 24 (4). S. 315 - 322. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0415